Tag: post-approval surveillance

How FDA Monitors Generic Drug Safety After Approval
25, June, 2026

How FDA Monitors Generic Drug Safety After Approval

Explore how the FDA monitors generic drug safety after approval using DQRS, MedWatch, and advanced signal detection. Learn about the Weber Effect, therapeutic inequivalence challenges, and future AI-driven improvements.

Read more